Schedule 13G ownership disclosure

TURNING POINT THERAPEUTICS I

Security class unavailable · CUSIP: 90041T108

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,009,654
Percent of class
8.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001678858-22-000240
Form type
SC 13G
Filer
Turning Point Therapeutics, Inc.
CIK
CIK 1595893
Filed
Feb 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub